IPO Readiness Checklist: A Practical Checklist

Document type: Checklist Practice area: Corporate — Securities Jurisdiction: United States (federal) Last reviewed: 5 September 2026

Part 1 — Financial reporting (start eighteen months out)

This is the long pole. Everything else waits on it.

Historical financials auditable under Regulation S-X, 17 C.F.R. Part 210 for the required periods. (Reviewed or compiled statements are not sufficient.)
Auditor is registered with the PCAOB and applies the applicable auditing standards. (Statements audited by an unregistered firm must be re-audited — a six-month discovery.)
Revenue recognition applied consistently and defensible on a fresh audit.
Any restatement identified and completed before filing, privately.
Staleness dates mapped — they drive the entire timetable; missing a window adds a quarter.
Acquisition financial statements and pro formas assessed against the significance tests.
Segment reporting reviewed; non-GAAP measures, prominence, and reconciliations reviewed.
Close process shortened to fit a filing deadline (target: single digits, not weeks).
Public-company accounting staff hired ahead of need — technical accounting resource, additional accountants, internal audit function.

Part 2 — Internal control

Processes documented; controls designed and tested.
Deficiencies identified and remediated before filing — material weaknesses are disclosable and are read as a signal about management.
Management's assessment framework in place for the first annual report.
Emerging growth company auditor-attestation transition understood.
Disclosure controls and procedures designed; disclosure committee constituted.

Part 3 — Capitalization and corporate records

Every equity issuance authorized and documented.
Every option grant approved, correctly priced, and evidenced — missing written consents are the recurring defect.
Convertible instruments and conversion mechanics confirmed.
Stockholder, voting, and registration rights agreements identified for termination or amendment.
Curative resolutions, ratifications, and — where a former holder is affected — confirmations or releases obtained.
Charter and bylaws in public-company form.
Cap table reconciled to the corporate records, not to the spreadsheet.

Part 4 — Board and governance

Independent directors recruited early — this takes months.
Audit committee financial expert identified first — hardest seat, most consequential.
Compensation and nominating committees constituted.
Committees meeting and functioning before filing, not newly formed at signature.
Director background checks completed (results appear in the prospectus).
Directors briefed on meeting load, personal § 11 exposure, the D&O program and its Side A tower, indemnification agreements, ownership guidelines, and trading restrictions.
Policy set adopted: code of conduct, insider trading, disclosure, related party transactions, clawback.
Controlled company status and available exchange exemptions assessed.

Part 5 — Contracts and what becomes public

Material contracts identified eighteen months out.
Reviewed for change-of-control provisions and for confidentiality terms that filing would breach.
Confidentiality provisions renegotiated before there is a timetable — counterparties are far more accommodating then.
Confidential treatment strategy planned for commercially sensitive terms, with the competitive harm rationale prepared. (Over-redaction draws a comment.)
Counterparties told in advance that their agreement will be filed.
Exhibit index drafted early: charter, bylaws, equity plans, executive employment and severance agreements, indemnification agreements, subsidiary list, credit facility, key licenses and customer agreements.

Part 6 — The business problems the assessment surfaces

Customer concentration measured and, where possible, reduced.
Key person dependence addressed.
Single-source supplier risk addressed.
Litigation assessed and resolved or reserved.
Regulatory compliance documented.
Intellectual property ownership confirmed and chain of title cleaned.
Understood: these become risk factors and investor questions — the year before filing is the last chance to improve them.

Part 7 — Route selection

Underwritten offering — primary capital, price certainty, underwriters as § 11 defendants whose diligence protects the directors; costs the gross spread and locks up holders.
Direct listing — no spread, no traditional lockup, no primary capital in the classic form; materially narrower § 11 exposure after Slack Technologies, LLC v. Pirani, 598 U.S. 759 (2023) because of the tracing requirement, but § 12 and Rule 10b-5 exposure remains.
De-SPAC — negotiated valuation; assess realistic post-redemption cash, the sponsor promote and dilution, diligence quality, and whether the projections will survive scrutiny.
Decision made deliberately, with the process value of the underwritten route weighed.

Part 8 — Working group and organizational meeting

Underwriters chosen on sector expertise, research, distribution, and the individuals who will run the deal.
Issuer's counsel with real offering experience in the sector.
Auditors confirmed able to deliver on the timetable.
Organizational meeting held: timetable agreed, drafting responsibility allocated, diligence plan set.
Timetable assumes the Commission review adds two to three months.
Workstream owners named: business, risk factors, MD&A, financials, compensation, related party, exhibits, diligence record.
Communications policy imposed from this meeting forward (Part 11).

Part 9 — The registration statement

Business section accurate rather than promotional — market claims sourced, "leading" supported, roadmap not described in the present tense.
Risk factors specific to this company, quantified where possible, ordered by importance.
No materialized risk framed as hypothetical. (If the customer gave notice, the risk factor does not say "we may lose customers.")
Risk factors cross-checked against MD&A and against the diligence file; re-read after final diligence.
MD&A covers results with reasons, liquidity, critical estimates, and — the requirement most often thin — known trends and uncertainties.
Every "we believe" tested: after Omnicare, Inc. v. Laborers District Council Construction Industry Pension Fund, 575 U.S. 175 (2015), an opinion is untrue if not sincerely held and may be actionable as an omission if it omits material facts about the inquiry behind it. If the belief rests on nothing, or the files show contrary advice, the sentence comes out.
Use of proceeds, capitalization, dilution, compensation, related party transactions, principal stockholders, capital stock description, shares eligible for future sale.
Drafting sessions held — whole group, aloud, line by line.

Part 10 — The due diligence record

Everything here supports the § 11 due diligence defense for directors and underwriters.

Management diligence sessions by function, with counsel, minuted.
Document diligence: corporate, contracts, financing, IP, litigation, regulatory, insurance, employment, benefits, real property.
Third-party diligence: customer and supplier calls; director and officer background checks; technical diligence where needed.
Backup binder tying every factual assertion, statistic, and superlative in the prospectus to a source — built as you draft, not reconstructed in week nine.
Comfort letter scope negotiated; tick-and-tie completed.
Legal opinions and 10b-5 negative assurance letters from issuer's and underwriters' counsel.
Officer certificates at pricing and closing.
Diligence file organized to be produced if a claim is filed.

Part 11 — Communications discipline

Understood: § 5(c) prohibits offers before filing, construed broadly to include conduct conditioning the market.
Rule applied: keep doing exactly what you have always done, at the same cadence, and change nothing because of the offering.
One approval path, one named approver, covering press, social media, conferences, customer and partner communications, recruiting materials, and executive interviews.
Runs from the organizational meeting through the end of the lockup.
Whole company briefed — an enthusiastic sales email or recruiting post is a problem nobody intended.
Testing-the-waters communications conducted through the underwriters, on a controlled basis.
Free writing prospectus conditions understood, including filing.
Road show: nothing said that is not in the prospectus. Deck and script retained; meetings logged.

Part 12 — Submission, comments, and EGC accommodations

Confidential submission used — the comment process runs before anything is public, and postponement reveals nothing.
Emerging growth company accommodations assessed: reduced audited periods, reduced compensation disclosure, auditor attestation relief, permitted research. Decision made deliberately whether to provide more than required.
Comments anticipated on: revenue recognition disclosure; non-GAAP prominence and reconciliation; risk factor specificity; known trends and uncertainties; segments; acquisition financials and pro formas; market position claims.
Numbered response letter answering every comment — change made, or precise explanation why not.
No lengthy argument over a comment that will ultimately be accepted (it costs a round).
Pre-filing consultation used for novel accounting or structural questions.

Part 13 — Governance decisions before pricing

Presented to the board as a package at least three months before filing, with trade-offs.

Dual-class structure — index eligibility, investor policies, proxy adviser positions, and the sunset provision.
Board classification — defensive value versus governance cost.
Exclusive forum for internal corporate claims; federal forum provision for Securities Act claims.
Advance notice bylaws; special meeting and written consent rights; supermajority provisions.
Controlled company exemptions.
Indemnification to the fullest extent permitted; individual indemnification agreements; D&O program placed before the road show.
Equity plan reserve, evergreen provision, and treatment of pre-offering awards.
Exchange and state of incorporation chosen rather than defaulted.

Part 14 — Pricing, closing, and the lockup

Range set with an understanding that it is a marketing device as much as a valuation.
Management rehearsed with hostile questions; deflection taught ("that isn't something we've disclosed").
Guidance policy decided before the first investor meeting, not in response to pressure.
Pricing treated as a board decision, not a ratification — price, size, and the proceeds-versus-aftermarket trade-off understood.
Allocation interest expressed to the underwriters (quality and stickiness of the shareholder base).
Underwriting agreement terms reviewed: gross spread, over-allotment option, representations, closing conditions, indemnification and contribution, market-out clause, and expense provisions.
Lockup terms understood: duration, early release triggers, and carve-outs for estate planning, charitable gifts, and 10b5-1 plan adoption.
Stop-or-postpone conditions agreed in advance — floor price, triggering events, and who decides.

Part 15 — The first quarter as a public company

Reporting calendar under 15 U.S.C. § 78m mapped to the close process.
Disclosure committee meeting before each filing, with a documented process.
Earnings script, review process, and non-GAAP reconciliations ready.
Regulation FD training delivered — the common violation is a well-meaning answer in a one-on-one investor meeting.
Section 16 reporting operating for officers, directors, and ten percent holders; short-swing profit rule explained, including for routine plan transactions.
Insider trading controls live: blackout periods, pre-clearance, 10b5-1 plans adopted in open windows with cooling-off periods observed.
Internal control assessment underway for the first annual report.
Exchange listing standards satisfied and monitored.
Proxy season planned: annual meeting, say-on-pay, compensation discussion and analysis, proxy adviser engagement.
Controls operating before the first quarter closes — a miss will draw a securities class action, and the defense rests on the disclosure and the process behind it.